The finding that DFATs suppressed the IL-6 and CCL2 levels indicated that DFAT cells inhibited intestinal inflammation and/or promoted intestinal regeneration in the NEC rat model, leading to intestinal damage amelioration/prevention and survival rate improvement. The gene discussed is CCL2; the disease is necrotizing enterocolitis.